// App-Quantinova.ai

: CMET-30. COMPREHENSIVE METHYLOME ANALYSIS OF EGFR-MUTANT PRIMARY LUNG ADENOCARCINOMA AND MATCHED BRAIN METASTASIS

Researchers

Presenter

  • Yasin Mamatjan

Principal Investigators

  • Michael Cabanero

  • Jeffrey Zuccato

  • Jessica Weiss

  • Shirin Karimi

  • Hadas Sorotsky

  • Ming Tsao

  • Kenneth Aldape

  • Frances Shepherd

  • Gelareh Zadeh

Medical Centers

  • MacFeeters-Hamilton Centre for Neuro-Oncology Research, Princess Margaret Cancer Center, Toronto, ON, Canada

  • Department of Laboratory Medicine and Pathology, University of Toronto, University Health Network, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • MacFeeters-Hamilton Centre for Neuro-Oncology Research, Princess Margaret Cancer Center, Toronto, ON, Canada

  • Laboratory of Tumor Immunology and Biology, National Cancer Institute at the National Institutes of Health, Bethesda, MD

  • Universtiy Health Network, Toronto, ON, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Brain metastasis

Biomarkers

  • Anaplastic lymphoma Kinase

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A